AJJ Medtech announced a new institutional medical supply contract worth approximately S$3 million, covering biodegradable medical consumables. The contract starts on 1 June 2026, with an initial 2-year term and an extension option, while the company’s cumulative institutional revenue pipeline now exceeds S$8 million.
[AI-readable]
Company: AJJ Medtech Holdings Limited
Ticker: SGX: 584
Announcement Date: 9 March 2026
Announcement Title: AJJ Medtech Secures S$3M Institutional Contract for Biodegradable Medical Consumables
Contracting Entity: AJJ Healthcare Management Pte. Ltd. (wholly owned subsidiary)
Customer Type: A network of Singapore healthcare institutions
Contract Value: Approximately S$3 million
Product Category: Biodegradable medical consumables
Commencement Date: 1 June 2026
Contract Term: Initial two-year term with an option to extend for a further two years
Institutional Revenue Pipeline: Exceeds S$8 million
Financial Impact: Not expected to have a material impact on current financial year NTA or EPS; expected to contribute positively over the contract tenure.
Comments